89 related articles for article (PubMed ID: 8447668)
1. Proliferation characteristics of cutaneous squamous cell carcinomas developing in organ graft recipients. Comparison with squamous cell carcinomas of nonimmunocompromised hosts by counting argyrophilic proteins associated with nucleolar organizer regions.
Hoyo E; Kanitakis J; Euvrard S; Thivolet J
Arch Dermatol; 1993 Mar; 129(3):324-7. PubMed ID: 8447668
[TBL] [Abstract][Full Text] [Related]
2. Silver-stained organizer regions and immunoglobulins in cutaneous keratoacanthomas and squamous cell carcinomas.
Aroni K; Mastoraki A; Kyriazi E; Ioannidis E; Patsouris E
Pathol Res Pract; 2007; 203(9):659-65. PubMed ID: 17673372
[TBL] [Abstract][Full Text] [Related]
3. Silver-stained nucleolar organizer regions and immunoglobulins in cutaneous squamocellular tumors.
Aroni K; Mastoraki A; Kyriazi E; Liossi A; Ioannidis E
Pathol Res Pract; 2007; 203(12):857-62. PubMed ID: 17949923
[TBL] [Abstract][Full Text] [Related]
4. The occurrence of residual or recurrent squamous cell carcinomas in organ transplant recipients after curettage and electrodesiccation.
de Graaf YG; Basdew VR; van Zwan-Kralt N; Willemze R; Bavinck JN
Br J Dermatol; 2006 Mar; 154(3):493-7. PubMed ID: 16445781
[TBL] [Abstract][Full Text] [Related]
5. Expression of Fas and Fas-ligand and analysis of argyrophilic nucleolar organizer regions in squamous cell carcinoma: relationships with tumor stage and grade, and apoptosis.
Guler N; Uckan S; Celik I; Oznurlu Y; Uckan D
Int J Oral Maxillofac Surg; 2005 Dec; 34(8):900-6. PubMed ID: 15907374
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic application of detecting AgNOR in peripheral blood T lymphocyte in patients with esophageal carcinoma].
Wang JY; Rong TH; Liang YR; Long H; Chen QL; Ma GW
Ai Zheng; 2004 May; 23(5):577-80. PubMed ID: 15142458
[TBL] [Abstract][Full Text] [Related]
7. Differences in the peritumoural inflammatory skin infiltrate between squamous cell carcinomas in organ transplant recipients and immunocompetent patients.
Krynitz B; Lundh Rozell B; Lindelöf B
Acta Derm Venereol; 2010 Jul; 90(4):379-85. PubMed ID: 20574603
[TBL] [Abstract][Full Text] [Related]
8. Low-dose retinoids in the prevention of cutaneous squamous cell carcinomas in organ transplant recipients: a 16-year retrospective study.
Harwood CA; Leedham-Green M; Leigh IM; Proby CM
Arch Dermatol; 2005 Apr; 141(4):456-64. PubMed ID: 15837863
[TBL] [Abstract][Full Text] [Related]
9. Nucleolar organizer regions (NORs) in dysplastic and neoplastic epithelial lesions of the conjunctiva.
Muscarà M; Giuffré G; Trombetta CJ; Bisantis F; Tuccari G
Pathologica; 1991; 83(1085):281-8. PubMed ID: 1923626
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase-26 is present more frequently in squamous cell carcinomas of immunosuppressed compared with immunocompetent patients.
Kuivanen T; Jeskanen L; Kyllönen L; Isaka K; Saarialho-Kere U
J Cutan Pathol; 2009 Sep; 36(9):929-36. PubMed ID: 19674198
[TBL] [Abstract][Full Text] [Related]
11. Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis.
Pich A; Chiusa L; Margaria E
Cancer Detect Prev; 1995; 19(3):282-91. PubMed ID: 7750118
[TBL] [Abstract][Full Text] [Related]
12. Progression of cutaneous squamous cell carcinoma in immunosuppressed patients is associated with reduced CD123+ and FOXP3+ cells in the perineoplastic inflammatory infiltrate.
Mühleisen B; Petrov I; Gächter T; Kurrer M; Schärer L; Dummer R; French LE; Hofbauer GF
Histopathology; 2009 Jul; 55(1):67-76. PubMed ID: 19614769
[TBL] [Abstract][Full Text] [Related]
13. The different telomere lengths in basal and squamous cell carcinomas also differ between the nontransplant and renal transplant population.
Perrem K; Lynch A; Al Nooh F; Leader M; Elaine Kay
Hum Pathol; 2008 Jul; 39(7):1034-41. PubMed ID: 18482746
[TBL] [Abstract][Full Text] [Related]
14. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients.
Fortina AB; Piaserico S; Caforio AL; Abeni D; Alaibac M; Angelini A; Iliceto S; Peserico A
Arch Dermatol; 2004 Sep; 140(9):1079-85. PubMed ID: 15381547
[TBL] [Abstract][Full Text] [Related]
16. Basal cell carcinomas developing in solid organ transplant recipients: clinicopathologic study of 176 cases.
Kanitakis J; Alhaj-Ibrahim L; Euvrard S; Claudy A
Arch Dermatol; 2003 Sep; 139(9):1133-7. PubMed ID: 12975154
[TBL] [Abstract][Full Text] [Related]
17. Conversion from calcineurin inhibitors to sirolimus reduces vascularization and thickness of post-transplant cutaneous squamous cell carcinomas.
Rival-Tringali AL; Euvrard S; Decullier E; Claudy A; Faure M; Kanitakis J
Anticancer Res; 2009 Jun; 29(6):1927-32. PubMed ID: 19528449
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the nucleolar organizer region associated proteins in oral squamous cell carcinoma.
Epivatianos A
Ann Dent; 1994; 53(1):33-6. PubMed ID: 8060107
[TBL] [Abstract][Full Text] [Related]
19. [Estimation of proliferative activity of experimental tongue papillomas and carcinomas in rats--comparison with DNA cytofluorometric analysis and silver-stained nucleolar organizer regions].
Itoh T; Yamamoto Y; Saka T; Takahashi H
Gan To Kagaku Ryoho; 1993 Apr; 20(6):839-42. PubMed ID: 8489295
[TBL] [Abstract][Full Text] [Related]
20. In-transit metastasis from primary cutaneous squamous cell carcinoma in organ transplant recipients and nonimmunosuppressed patients: clinical characteristics, management, and outcome in a series of 21 patients.
Carucci JA; Martinez JC; Zeitouni NC; Christenson L; Coldiron B; Zweibel S; Otley CC
Dermatol Surg; 2004 Apr; 30(4 Pt 2):651-5. PubMed ID: 15061850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
